|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - Corvus Pharmaceuticals Inc. (CRVS)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2018-12-27 Purchase |
2018-12-31 4:16 pm |
Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO |
20,000 | $3.294 | $65,884 | 1,128,795 (Indirect) |
View |
| 2018-12-21 Purchase |
2018-12-27 4:08 pm |
Corvus Pharmaceuticals Inc. | CRVS | LEA LEIV CFO |
24,700 | $4.146 | $102,409 | 149,206 (Indirect) |
View |
| 2018-12-20 Purchase |
2018-12-26 4:05 pm |
Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO |
10,000 | $4.395 | $43,950 | 1,108,795 (Indirect) |
View |
| 2018-12-06 Purchase |
2018-12-10 4:05 pm |
Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO |
5,000 | $5.987 | $29,934 | 1,118,795 (Indirect) |
View |
| 2018-12-04 Purchase |
2018-12-06 4:06 pm |
Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO |
1,502 | $5.95 | $8,937 | 1,113,795 (Indirect) |
View |
| 2018-03-12 Purchase |
2018-03-14 2:05 pm |
Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director, 10% Owner |
588,235 | $8.5 | $4,999,998 | 5,967,584 (Indirect) |
View |
| 2018-03-12 Purchase |
2018-03-14 1:58 pm |
Corvus Pharmaceuticals Inc. | CRVS | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC Director, 10% Owner |
588,235 | $8.5 | $4,999,998 | 5,967,584 (Indirect) |
View |
| 2018-03-12 Purchase |
2018-03-13 5:12 pm |
Corvus Pharmaceuticals Inc. | CRVS | Novo Holdings A/S 10% Owner |
1,176,470 | $8.5 | $9,999,995 | 4,420,516 (Direct) |
View |
| 2018-03-12 Purchase |
2018-03-13 4:07 pm |
Corvus Pharmaceuticals Inc. | CRVS | Gould Terry P Director, 10% Owner |
588,235 | $8.5 | $4,999,998 | 2,687,381 (Indirect) |
View |
| 2018-03-12 Purchase |
2018-03-13 3:30 pm |
Corvus Pharmaceuticals Inc. | CRVS | ADAMS STREET PARTNERS LLC 10% Owner |
588,235 | $8.5 | $4,999,998 | 2,687,381 (Indirect) |
View |
| 2018-03-12 Purchase |
2018-03-12 4:05 pm |
Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO |
100,000 | $8.5 | $850,000 | 1,112,293 (Indirect) |
View |
| 2017-11-20 Purchase |
2017-11-22 4:06 pm |
Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO |
10,000 | $10.78 | $107,850 | 1,012,293 (Indirect) |
View |
| 2017-06-23 Purchase |
2017-06-27 4:52 pm |
Corvus Pharmaceuticals Inc. | CRVS | Novo Holdings A/S 10% Owner |
20,000 | $10.95 | $219,000 | 3,244,046 (Direct) |
View |
| 2017-06-09 Purchase |
2017-06-13 4:06 pm |
Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO |
25,000 | $9.883 | $247,084 | 1,002,293 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-01-28 Option Award |
2019-01-30 4:08 pm |
N/A 2029-01-28 |
Corvus Pharmaceuticals Inc. | CRVS | Grais Linda S Director |
30,000 | $3.88 | 30,000 (Direct) |
View |
| 2019-01-28 Option Award |
2019-01-30 4:07 pm |
N/A 2029-01-28 |
Corvus Pharmaceuticals Inc. | CRVS | Mobasher Mehrdad Chief Medical Officer |
210,000 | $3.88 | 210,000 (Direct) |
View |
| 2018-12-12 Option Award |
2018-12-14 4:09 pm |
N/A 2028-12-12 |
Corvus Pharmaceuticals Inc. | CRVS | Jones William Benton See Remarks |
100,000 | $5.94 | 113,773 (Direct) |
View |
| 2018-12-12 Gift |
2018-12-14 4:07 pm |
N/A N/A |
Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO |
10,000 | $0 | 1,108,795 (Indirect) |
View |
| 2018-12-12 Gift |
2018-12-14 4:07 pm |
N/A N/A |
Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO |
10,000 | $0 | 1,108,795 (Indirect) |
View |
| 2018-12-12 Option Award |
2018-12-14 4:07 pm |
N/A 2028-12-12 |
Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO |
250,000 | $5.94 | 1,108,795 (Direct) |
View |
| 2018-12-12 Option Award |
2018-12-14 4:06 pm |
N/A 2028-12-12 |
Corvus Pharmaceuticals Inc. | CRVS | Buggy Joseph J VP |
100,000 | $5.94 | 266,310 (Direct) |
View |
| 2018-12-12 Option Award |
2018-12-14 4:06 pm |
N/A 2028-12-12 |
Corvus Pharmaceuticals Inc. | CRVS | LEA LEIV CFO |
100,000 | $5.94 | 149,206 (Direct) |
View |
| 2018-12-12 Option Award |
2018-12-14 4:05 pm |
N/A 2028-12-12 |
Corvus Pharmaceuticals Inc. | CRVS | Hunt Daniel W. SVP, Chief Business Officer |
50,000 | $5.94 | 50,000 (Direct) |
View |
| 2018-12-12 Option Award |
2018-12-14 4:05 pm |
N/A 2028-12-12 |
Corvus Pharmaceuticals Inc. | CRVS | Verner Erik J. VP |
50,000 | $5.94 | 63,773 (Direct) |
View |
| 2018-06-21 Option Award |
2018-06-25 4:15 pm |
N/A 2028-06-21 |
Corvus Pharmaceuticals Inc. | CRVS | ADAMS STREET PARTNERS LLC 10% Owner |
15,000 | $12.5 | 3,275,616 (Indirect) |
View |
| 2018-06-21 Option Award |
2018-06-25 4:06 pm |
N/A 2028-06-21 |
Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director, 10% Owner |
15,000 | $12.5 | 5,967,584 (Direct) |
View |
| 2018-06-21 Option Award |
2018-06-25 4:05 pm |
N/A 2028-06-21 |
Corvus Pharmaceuticals Inc. | CRVS | Morrison Scott W Director |
15,000 | $12.5 | 15,000 (Direct) |
View |
| 2018-06-21 Option Award |
2018-06-25 4:05 pm |
N/A 2028-06-21 |
Corvus Pharmaceuticals Inc. | CRVS | Gould Terry P Director, 10% Owner |
15,000 | $12.5 | 3,275,616 (Direct) |
View |
| 2018-06-21 Option Award |
2018-06-25 4:05 pm |
N/A 2028-06-21 |
Corvus Pharmaceuticals Inc. | CRVS | CLARK IAN T Director |
15,000 | $12.5 | 15,000 (Direct) |
View |
| 2018-06-21 Option Award |
2018-06-25 4:05 pm |
N/A 2028-06-21 |
Corvus Pharmaceuticals Inc. | CRVS | Krognes Steve E. Director |
15,000 | $12.5 | 15,000 (Direct) |
View |
| 2018-01-19 Option Award |
2018-01-23 4:06 pm |
N/A 2028-01-19 |
Corvus Pharmaceuticals Inc. | CRVS | Buggy Joseph J VP |
100,000 | $9.94 | 266,310 (Direct) |
View |
| 2017-12-13 Option Award |
2017-12-15 4:13 pm |
N/A 2027-12-13 |
Corvus Pharmaceuticals Inc. | CRVS | Verner Erik J. VP |
25,000 | $10.6 | 63,773 (Direct) |
View |
| 2017-12-13 Option Award |
2017-12-15 4:10 pm |
N/A 2027-12-13 |
Corvus Pharmaceuticals Inc. | CRVS | Jones William Benton See Remarks |
40,000 | $10.6 | 113,773 (Direct) |
View |
| 2017-12-13 Option Award |
2017-12-15 4:09 pm |
N/A 2027-12-13 |
Corvus Pharmaceuticals Inc. | CRVS | Hunt Daniel W. SVP, Chief Business Officer |
200,000 | $10.6 | 200,000 (Direct) |
View |
| 2017-12-13 Option Award |
2017-12-15 4:08 pm |
N/A 2027-12-13 |
Corvus Pharmaceuticals Inc. | CRVS | LEA LEIV CFO |
40,000 | $10.6 | 149,206 (Direct) |
View |
| 2017-12-13 Option Award |
2017-12-15 4:06 pm |
N/A 2027-12-13 |
Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO |
125,000 | $10.6 | 1,012,293 (Direct) |
View |
| 2017-06-08 Option Award |
2017-06-09 4:06 pm |
N/A 2027-06-08 |
Corvus Pharmaceuticals Inc. | CRVS | Gould Terry P Director, 10% Owner |
15,000 | $9.7 | 736,033 (Direct) |
View |
| 2017-06-08 Option Award |
2017-06-09 4:06 pm |
N/A 2027-06-08 |
Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director, 10% Owner |
15,000 | $9.7 | 5,379,349 (Direct) |
View |
| 2017-06-08 Option Award |
2017-06-09 4:05 pm |
N/A 2027-06-08 |
Corvus Pharmaceuticals Inc. | CRVS | Krognes Steve E. Director |
15,000 | $9.7 | 15,000 (Direct) |
View |
| 2017-06-08 Option Award |
2017-06-09 4:05 pm |
N/A 2027-06-08 |
Corvus Pharmaceuticals Inc. | CRVS | CLARK IAN T Director |
15,000 | $9.7 | 15,000 (Direct) |
View |
| 2017-06-08 Option Award |
2017-06-09 4:05 pm |
N/A 2027-06-08 |
Corvus Pharmaceuticals Inc. | CRVS | Morrison Scott W Director |
15,000 | $9.7 | 15,000 (Direct) |
View |
| 2017-06-08 Option Award |
2017-06-09 4:01 pm |
N/A 2027-06-08 |
Corvus Pharmaceuticals Inc. | CRVS | ADAMS STREET PARTNERS LLC 10% Owner |
15,000 | $9.7 | 736,033 (Indirect) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Thu, 23 May 2019 22:39:10 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |